IMM 6.25% 30.0¢ immutep limited

Looks like we finally have the tick....FDA ApplicationResults...

  1. 486 Posts.
    lightbulb Created with Sketch. 10
    Looks like we finally have the tick....


    FDA ApplicationResults for Orphan Drug Product Designations Search
    Return to Orphan Designation Search Page
    Result Number: 1
    Generic Name: Autologous Dendritic Cells Pulsed With Recombinant Human Fusion Protein (Mucin1- Glutathione S Transferase) Coupled To Oxidized Polymannose
    Trade Name: Cvac(Tm)
    Date Designated: 09-13-2010
    Orphan Designation: Treatment of ovarian cancer.
    Orphan Designation Status: Designated
    FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
    Sponsor: Prima Biomed Ltd.
    1233 High Street
    Suite 1
    Armadale, Victoria 3143
    AUSTRALIA

    ---
    http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=315510


 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.020(6.25%)
Mkt cap ! $435.7M
Open High Low Value Volume
31.5¢ 31.5¢ 29.5¢ $2.355M 7.796M

Buyers (Bids)

No. Vol. Price($)
8 128197 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 100000 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.